Foot and Mouth Disease Diagnostics Global Market Report 2026

The foot and mouth disease diagnostics market size has grown strongly in recent years. It will grow from $1.06 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to recurring outbreaks of foot and mouth disease, increasing livestock population globally, expansion of veterinary diagnostic laboratories, government-led disease surveillance programs, rising awareness about animal health management.

The foot and mouth disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing demand for early and rapid disease detection, increasing investment in veterinary healthcare infrastructure, expansion of molecular diagnostic technologies, rising cross-border livestock trade monitoring, development of portable diagnostic instruments. Major trends in the forecast period include increasing adoption of real-time PCR diagnostic kits, growing demand for rapid point-of-care testing, expansion of multiplex assay development, rising use of lateral flow immunoassays in field settings, development of high-sensitivity ELISA kits.

The increasing livestock populations are expected to stimulate the growth of the foot and mouth disease diagnostics market going forward. Livestock populations refer to the total number of domesticated animals, including cattle, pigs, and sheep, raised for food production, dairy, or other economic purposes. These populations are expanding due to the rising global demand for meat and dairy products, prompting farmers to maintain larger herds. Higher animal densities increase the risk of rapid disease transmission, creating a greater need for early detection and ongoing disease surveillance to prevent large-scale outbreaks and economic losses. For instance, in June 2025, according to the Australian Bureau of Statistics, an Australian-based government administration, there were 30.4 million cattle on farms as of 30 June 2024, representing a 1.6% increase compared to June 2023. Therefore, the rising livestock populations are driving the growth of the foot and mouth disease diagnostics market.

Leading companies operating in the foot and mouth disease diagnostics market are focusing on developing innovative methods such as real-time polymerase chain reaction (PCR) assays to enable faster and more accurate detection of FMD outbreaks. Real-time PCR assays are molecular tests that detect and quantify viral genetic material in real time, helping to identify foot and mouth disease quickly and accurately for effective outbreak control. For example, in May 2025, BioStone Animal Health LLC, a US-based biotechnology company, launched AsurDx Real-Time PCR kits for FMD detection, an advanced molecular diagnostic solution designed for rapid, sensitive, and multiplex detection of multiple FMD virus types (A, O, Asia1). The PCR kits contain pre-validated reaction mixes, primers, probes, enzymes, and all necessary reagents and controls, making setup fast and reliable. They are compatible with a wide range of thermal cyclers and enable quantitative detection of viral genes with high accuracy and reproducibility. These PCR kits provide faster and more precise results compared to traditional ELISA tests, supporting routine diagnostics, outbreak monitoring, and global surveillance programs, and strengthening FMD control efforts worldwide.

In February 2023, Tetracore, Inc, a US-based company developing innovative kits, assays, and reagents for detecting infectious diseases, biological warfare agents, and biological markers, partnered with the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) to supply USDA-licensed PCR test kits for African Swine Fever (ASF) and Foot-and-Mouth Disease (FMD) to the National Animal Vaccine and Veterinary Countermeasures Bank. These validated, updated diagnostic kits will enable the U.S. to rapidly detect and respond to potential high-impact foreign animal disease outbreaks, safeguarding the livestock industry and food supply.

Major companies operating in the foot mouth disease diagnostics market are Thermo Fisher Scientific Inc., Zoetis Inc., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Neogen Corporation, IDvet Inc., Creative Diagnostics Inc., Krishgen Biosystems Pvt. Ltd., AdvaCare Pharma Inc., Biovet Inc., Acro Biotech Inc., Ring Biotechnology Co. Ltd., BioNote Inc., BIO X Diagnostics Inc., GlobalVet Solutions LLC, Median Diagnostics Inc., BioVenic Inc., Avicena LLC, Svanova Biotech AB.

North America was the largest region in the foot and mouth disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the foot and mouth disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the foot and mouth disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The foot and mouth disease diagnostics market consists of sales of diagnostic test kits, reagents, assay systems, molecular testing solutions, serological testing products, and related laboratory instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Foot and mouth disease diagnostics are laboratory and point-of-care techniques used to detect the foot and mouth disease virus in animals. These methods identify viral antigens, genetic material, or antibodies to confirm infection and facilitate rapid disease control measures. They are crucial for timely detection, effective outbreak management, and minimizing disease spread among livestock.

The key techniques of foot and mouth disease diagnostics include enzyme-linked immunosorbent assay (ELISA) kits, polymerase chain reaction (PCR) kits, immunoassays, chromatography, and other methods. ELISA kits are ready-to-use tools that detect and quantify specific proteins, antigens, or antibodies in a sample through enzyme-mediated color changes. Product types include kits and reagents, instruments, software, and other variants, covering animal types such as cattle, swine, sheep, goats, and others. End users include veterinary hospitals and clinics, diagnostic laboratories, research institutes, and other organizations.

Tariffs on imported diagnostic kits, reagents, laboratory instruments, and molecular testing components are influencing the foot and mouth disease diagnostics market by increasing procurement costs for veterinary hospitals and diagnostic laboratories. Segments such as PCR kits and ELISA kits are particularly affected due to their reliance on specialized imported reagents and equipment. Regions dependent on global biotech supply chains, including Asia-Pacific, Africa, and parts of Latin America, experience higher cost burdens. However, tariffs are also promoting domestic manufacturing of veterinary diagnostic kits and encouraging regional production capabilities, strengthening local supply chains and supporting long-term market growth.

The foot and mouth disease diagnostics market research report is one of a series of new reports that provides foot and mouth disease diagnostics market statistics, including foot and mouth disease diagnostics industry global market size, regional shares, competitors with a foot and mouth disease diagnostics market share, detailed foot and mouth disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the foot and mouth disease diagnostics industry. This foot and mouth disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.